P. Plazzi

发表

Melatonin receptor ligands: synthesis of new melatonin derivatives and comprehensive comparative molecular field analysis (CoMFA) study.

R. Nonno, M. Mor, G. Tarzia, 1998, Journal of medicinal chemistry.

Synthesis and Stability in Biological Media of 1H‐Imidazole‐1‐carboxylates of ROS203, an Antagonist of the Histamine H3 Receptor

M. Mor, L. Flammini, V. Ballabeni, 2008, Chemistry & biodiversity.

Antioxidant and cytoprotective activity of indole derivatives related to melatonin.

Claudia Silva, Marco Mor, Federica Vacondio, 2003, Advances in experimental medicine and biology.

2-[N-Acylamino(C1-C3)alkyl]indoles as MT1 melatonin receptor partial agonists, antagonists, and putative inverse agonists.

R. Nonno, A. Tontini, M. Mor, 1998, Journal of medicinal chemistry.

2-N-acylaminoalkylindoles: design and quantitative structure-activity relationship studies leading to MT2-selective melatonin antagonists.

R. Nonno, A. Tontini, M. Mor, 2001, Journal of medicinal chemistry.

Compressed matrices: formulation and drug release kinetics

P. Colombo, P. Catellani, P. Plazzi, 1988 .

Synthesis and biological evaluation of new non-imidazole H3-receptor antagonists of the 2-aminobenzimidazole series.

M. Mor, V. Ballabeni, E. Barocelli, 2006, Bioorganic & medicinal chemistry.

Imidazole H3-antagonists: relationship between structure and ex vivo binding to rat brain H3-receptors.

P. Carrupt, B. Testa, M. Mor, 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Synthesis, biological activity, QSAR and QSPR study of 2-aminobenzimidazole derivatives as potent H3-antagonists.

M. Mor, M. Impicciatore, V. Ballabeni, 2004, Bioorganic & medicinal chemistry.

The role of HB-donor groups in the heterocyclic polar fragment of H3-antagonists. I. Synthesis and biological assays.

V. Ballabeni, E. Barocelli, S. Bertoni, 2003, Farmaco.

Synthesis and biological assays of new H3-antagonists with imidazole and imidazoline polar groups.

M. Mor, M. Impicciatore, V. Ballabeni, 2000, Farmaco.

Analysis of structure-activity relationships for MT2 selective antagonists by melatonin MT1 and MT2 receptor models.

M. Mor, G. Tarzia, S. Rivara, 2005, Journal of medicinal chemistry.

Cyclohexylcarbamic acid 3'- or 4'-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies.

Giovanni Piersanti, Daniele Piomelli, Alessio Lodola, 2004, Journal of medicinal chemistry.

Synthesis, pharmacological characterization and QSAR studies on 2-substituted indole melatonin receptor ligands.

R. Nonno, M. Mor, G. Tarzia, 2001, Bioorganic & medicinal chemistry.

Aryl azoles with neuroprotective activity--parallel synthesis and attempts at target identification.

G. Terstappen, G. Gaviraghi, A. Caricasole, 2008, Bioorganic & medicinal chemistry.

5-Benzylidene-hydantoins: synthesis and antiproliferative activity on A549 lung cancer cell line.

M. Mor, C. Carmi, P. Petronini, 2009, European journal of medicinal chemistry.

5-benzylidene-hydantoins as new EGFR inhibitors with antiproliferative activity.

M. Mor, C. Carmi, P. Petronini, 2006, Bioorganic & medicinal chemistry letters.

Heteroarylaminoethyl and Heteroarylthioethylimidazoles. Synthesis and H3-Receptor Affinity.

M. Mor, A. Caretta, E. Barocelli, 1996 .

Heteroarylaminoethyl and heteroarylthioethyl imidazoles. Synthesis and H3-receptor affinity

M. Mor, A. Caretta, E. Barocelli, 1995 .

[4-(3-Oxo-1,2-benzisothiazolin-2-yl)alkanoic, phenyl and phenoxyalkanoic acids: synthesis and anti-inflammatory, analgesic, and antipyretic properties].

M. Chiavarini, E. Barocelli, F. Bordi, 1989, Farmaco.

H2-antagonists: synthesis and activity of 2-amino-5-thiazolyl derivatives.

M. Impicciatore, F. Bordi, P. Catellani, 1989, Farmaco.

Conformationally restrained melatonin analogues: synthesis, binding affinity for the melatonin receptor, evaluation of the biological activity, and molecular modeling study.

R. Nonno, M. Mor, G. Tarzia, 1997, Journal of medicinal chemistry.

Synthesis, antioxidant activity and structure–activity relationships for a new series of 2‐(N‐acylaminoethyl)indoles with melatonin‐like cytoprotective activity

Claudia Silva, Marco Mor, Federica Vacondio, 2006, Journal of pineal research.

Experimental and theoretical analysis of the interaction of (+/-)-cis-ketoconazole with beta-cyclodextrin in the presence of (+)-L-tartaric acid.

M. Mor, P. Ventura, G. Fronza, 1999, Journal of pharmaceutical sciences.

Pharmacological activities of two new histamine analogs

M. Chiavarini, M. Impicciatore, F. Vitali, 1986, Agents and Actions.

H3-receptor antagonists: synthesis and structure-activity relationships of para- and meta-substituted 4(5)-phenyl-2-[[2-[4(5)-imidazolyl]ethyl]thio]imidazoles.

P. Carrupt, B. Testa, M. Mor, 1997, Journal of medicinal chemistry.

Synthesis and Structure–Activity Relationships of FAAH Inhibitors: Cyclohexylcarbamic Acid Biphenyl Esters with Chemical Modulation at the Proximal Phenyl Ring

A. Duranti, A. Tontini, M. Mor, 2006, ChemMedChem.

Design, synthesis, and structure-activity relationships of alkylcarbamic acid aryl esters, a new class of fatty acid amide hydrolase inhibitors.

A. Duranti, A. Tontini, M. Mor, 2003, Journal of medicinal chemistry.

Are histamine receptors involved in the stimulant activities of thiazolylethylamines supposed as cyclic models of dimaprit?

M. Chiavarini, M. Impicciatore, E. Barocelli, 1987, Agents and Actions.

QSAR study on H3-receptor affinity of benzothiazole derivatives of thioperamide.

M. Mor, A. Caretta, F. Bordi, 1994, Farmaco.

Mucus and pepsin role in gastric damage prevention by H2-receptor antagonists and antiulcer drugs.

M. Chiavarini, M. Impicciatore, G. Soldani, 1984, Acta physiologica Hungarica.

Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity.

M. Mor, L. Flammini, V. Ballabeni, 2008, Bioorganic & medicinal chemistry.

Three-dimensional quantitative structure-activity relationship studies on selected MT1 and MT2 melatonin receptor ligands: requirements for subtype selectivity and intrinsic activity modulation.

Claudia Silva, Silvia Rivara, Marco Mor, 2003, Journal of medicinal chemistry.

Indole‐based analogs of melatonin: in vitro antioxidant and cytoprotective activities

M. Mor, G. Tarzia, M. Zusso, 2004, Journal of pineal research.

Tricyclic alkylamides as melatonin receptor ligands with antagonist or inverse agonist activity.

M. Mor, G. Tarzia, F. Fraschini, 2004, Journal of Medicinal Chemistry.

Pharmacological characterization of H3 receptor antagonists with imidazole, thioimidazole and thioimidazoline polar groups in the side chain

M. Mor, M. Chiavarini, M. Impicciatore, 2000, Inflammation Research.

Validation of a histamine H3 receptor model through structure-activity relationships for classical H3 antagonists.

Silvia Rivara, Marco Mor, Simone Lorenzi, 2005, Bioorganic & medicinal chemistry.

Biological studies on 1,2-benzisothiazole derivatives V. Antimicrobial properties of N-alkanoic, N-arylalkanoic and N-aryloxyalkanoic derivatives of 1,2-benzisothiazolin-3-one: QSAR study and genotoxicity evaluation.

M. Mor, F. Zani, P. Mazza, 1996, Farmaco.

Dibasic non-imidazole histamine H3 receptor antagonists with a rigid biphenyl scaffold.

M. Mor, L. Flammini, V. Ballabeni, 2006, Bioorganic & medicinal chemistry letters.

Synthesis and binding assays of H3-receptor ligands.

M. Mor, M. Impicciatore, A. Caretta, 1992, Farmaco.

Rat Protein Binding and Cerebral Phospholipid Affinity of the H3‐receptor Antagonist Thioperamide

M. Mor, P. Crivori, A. Caretta, 1996, The Journal of pharmacy and pharmacology.

Synthesis and three-dimensional quantitative structure-activity relationship analysis of H3 receptor antagonists containing a neutral heterocyclic polar group.

P. Carrupt, B. Testa, M. Mor, 2003, Drug design and discovery.

Plasma concentration and brain penetration of the H3-receptor antagonist thioperamide in rats.

M. Mor, A. Caretta, V. Ballabeni, 1997, Il Farmaco.

Ligands of the histamine H3-receptor: new potent antagonists of the 2-thioimidazole type.

M. Mor, M. Impicciatore, A. Caretta, 1997, Il Farmaco.

Comparison of the effects of of structurally different H2-antagonists on acid and pepsin activity stimulated by dimaprit in conscious cats

M. Chiavarini, M. Impicciatore, E. Barocelli, 1985, Agents and Actions.

Influence of urea-equivalent groups in position 5 of 2-amino, 2-(1-aminoethylidenamino) and 2-guanidino thiazole derivatives on H2-receptor antagonist activity in gastric fistula cat

M. Chiavarini, M. Impicciatore, E. Barocelli, 1989, Agents and Actions.

Stimulation of acid and pepsin secretions in fistulated cats by dimaprit-like compounds.

M. Chiavarini, M. Impicciatore, P. Plazzi, 1980, Il Farmaco; edizione scientifica.

Application of 3D‐QSAR in the Rational Design of Receptor Ligands and Enzyme Inhibitors

A. Duranti, A. Tontini, M. Mor, 2005, Chemistry & biodiversity.